NICOLE ARCENTALES: Open Payments
NPI 1538314703 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,692 in 137 payments from 25 companies in 2025. Trend: 2023 $3,109 · 2024 $2,907 · 2025 $2,692
Food & beverage: $2,692
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 16 | $357 |
| ABBVIE INC. | 19 | $331 |
| AstraZeneca Pharmaceuticals LP | 9 | $273 |
| Novo Nordisk Inc | 12 | $243 |
| PFIZER INC. | 14 | $198 |
| Amgen Inc. | 11 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $136 |
| Axsome Therapeutics, Inc. | 6 | $130 |
| Sumitomo Pharma America, Inc. | 5 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
Products named: Kerendia, JARDIANCE, UBRELVY, FARXIGA, GEMTESA, OTEZLA, VRAYLAR, Auvelity.
Industry payments across NY — which companies pay providers there.
